- Home
- CCRN vs PROK Comparison
CCRN vs PROK Comparison
Compare CCRN & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCRN
- PROK
- Stock Information
- Founded
- CCRN 1986
- PROK 2015
- Country
- CCRN United States
- PROK United States
- Employees
- CCRN N/A
- PROK N/A
- Industry
- CCRN Professional Services
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CCRN Consumer Discretionary
- PROK Health Care
- Exchange
- CCRN Nasdaq
- PROK Nasdaq
- Market Cap
- CCRN 447.2M
- PROK 384.2M
- IPO Year
- CCRN N/A
- PROK N/A
- Fundamental
- Price
- CCRN $14.15
- PROK $2.41
- Analyst Decision
- CCRN Hold
- PROK Buy
- Analyst Count
- CCRN 5
- PROK 5
- Target Price
- CCRN $17.93
- PROK $6.25
- AVG Volume (30 Days)
- CCRN 264.1K
- PROK 2.5M
- Earning Date
- CCRN 08-06-2025
- PROK 08-12-2025
- Dividend Yield
- CCRN N/A
- PROK N/A
- EPS Growth
- CCRN N/A
- PROK N/A
- EPS
- CCRN N/A
- PROK N/A
- Revenue
- CCRN $1,192,539,000.00
- PROK $527,000.00
- Revenue This Year
- CCRN N/A
- PROK $105.79
- Revenue Next Year
- CCRN $5.58
- PROK N/A
- P/E Ratio
- CCRN N/A
- PROK N/A
- Revenue Growth
- CCRN N/A
- PROK N/A
- 52 Week Low
- CCRN $9.58
- PROK $0.46
- 52 Week High
- CCRN $18.33
- PROK $7.13
- Technical
- Relative Strength Index (RSI)
- CCRN 65.17
- PROK 47.47
- Support Level
- CCRN $13.55
- PROK $2.22
- Resistance Level
- CCRN $14.00
- PROK $2.59
- Average True Range (ATR)
- CCRN 0.45
- PROK 0.25
- MACD
- CCRN 0.11
- PROK -0.07
- Stochastic Oscillator
- CCRN 97.49
- PROK 22.03
About CCRN Cross Country Healthcare Inc. $0.0001 Par Value
Cross Country Healthcare Inc is a provider of total talent management services, including strategic workforce solutions, contingent staffing, permanent placement and consultative services for healthcare customers. The company operates in two business segments: the nurse and allied staffing segment, which generates a vast majority of revenue, offers temporary and permanent placements of travel and local nurses and allied professionals, and other outsourcing services.: the Physician Staffing segment provides licensed practitioners across a broad array of specialties, as well as certified registered nurse anesthetists (CRNAs), nurse practitioners (NPs), and physician assistants (PAs) on temporary assignments. The company earns majority of its revenue from the United States.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.